EARLY PHASE RESPIRATORY DRUG DEVELOPMENT RAPID, FREQUENT AND REPRODUCIBLE PK DATA COLLECTION FOR RESPIRATORY STUDIES. Our dedicated purpose built Early Phase campus conducts First-in-Human (FiH) through to Proof of Concept (PoC) studies with healthy volunteer and patient populations. We can work with respiratory experts from academia, teaching hospitals and have a respiratory advisory board of Key Opinion Leaders (KoLs) to assist us in delivering high quality respiratory studies to meet your business objectives.
We understand the importance of frequent, multiple early time-point collection to capture peak plasma concentration (c-max) results. WE ACHIEVE >95% OF FREQUENT EARLY PK TIME POINTS BECAUSE OF OUR EXPERIENCED STAFF AND OUR PROCESSES: • Qualified teams trained and maintained to meet our high standards • <10% staff turnover; experience and training is retained • Average length of service per staff member 10+ years • Cross functional teams, including research nurses, research physiologists, and research technicians, play a role in the dosing team.
SCREENING AND STUDY PROCESS:
Page1 of 2